0001157523-23-000430.txt : 20230314 0001157523-23-000430.hdr.sgml : 20230314 20230314070018 ACCESSION NUMBER: 0001157523-23-000430 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230314 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEXO Corp. CENTRAL INDEX KEY: 0001690947 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38781 FILM NUMBER: 23729150 BUSINESS ADDRESS: STREET 1: 120 CHEMIN DE LA RIVE CITY: GATINEAU STATE: A8 ZIP: J8M 1V2 BUSINESS PHONE: 1-844-406-1852 MAIL ADDRESS: STREET 1: 120 CHEMIN DE LA RIVE CITY: GATINEAU STATE: A8 ZIP: J8M 1V2 FORMER COMPANY: FORMER CONFORMED NAME: Hydropothecary Corp DATE OF NAME CHANGE: 20161128 6-K 1 a53361653.htm HEXO CORP. 6-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
 
 
For the month of March 2023
 
Commission File Number: 001-38781
 
HEXO Corp.
(Translation of registrant's name into English)

120 chemin de la Rive
Gatineau, Québec, Canada J8M 1V2
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ ] Form 40-F [ X ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Exhibit
Description
   


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
HEXO Corp.
   
   
Date: March 14, 2023
/s/ Julius Ivancsits
 
Chief Financial Officer

EX-99.1 2 a53361653ex99_1.htm EXHIBIT 99.1
Exhibit 99.1

HEXO to Host Second Quarter 2023 Earnings Conference Call

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021

GATINEAU, Québec--(BUSINESS WIRE)--March 14, 2023--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company"), a leading producer of high-quality cannabis products, announced today that it will hold an audio only conference call on March 17, 2023, at 10 a.m. EDT, to review its financial results for the second fiscal quarter, ended January 31, 2023. The results will be released after market close on Thursday, March 16, 2023.

Following the prepared remarks, there will be a question-and-answer session. Charlie Bowman, President & Chief Executive Officer, and Julius Ivancsits, Chief Financial Officer, will be participating on the call.

Conference Call Details
Date: Friday, March 17, 2023
Time: 10 a.m. EDT
Participant Toll-Free Dial-In Number: +1 888-440-5584
Participant Toll Dial-In Number: +1 646-960-0457
Conference ID: 6142858

Please dial-in 15 minutes before the start of the conference to secure a line and avoid delays. This conference call will be recorded and available for replay two hours after the call's completion until April 11, 2023, at 11:59 p.m. EDT.

To listen to the replay, please use the dial-in number listed below and the conference ID:

Toll Free Dial-in Number: +1 800-770-2030
Toll Dial-in Number: +1 647-362-9199

About HEXO Corp.
HEXO is an award-winning licensed producer of premium products for the global cannabis market. HEXO delivers a thoughtfully curated portfolio of both recreational and therapeutic cannabis products that inspire customer loyalty. HEXO’s brands include HEXO, Redecan, Original Stash, Bake Sale and T 2.0, as well as medical cannabis products.

HEXO’s world-class Canadian grow sites are unmatched in size, technological advantage and yield of high-quality cannabis, driving innovation through every step of the process. HEXO operates three major grow sites in Ontario and Québec, including one of the largest facilities in North America. HEXO Corp. is a publicly traded company under the tickers (TSX: HEXO) and (NASDAQ:HEXO).

Contacts

For media or investor inquiries:
Hayley Suchanek, Kaiser & Partners
hayley.suchanek@kaiserpartners.com